Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Achieve Life Sciences, Inc. (ACHV)

6.64   0.25 (3.91%) 05-16 02:16
Open: 6.424 Pre. Close: 6.39
High: 6.87 Low: 6.424
Volume: 51,106 Market Cap: 63(M)
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.88 - 6.91 6.91 - 6.93
Low: 6.36 - 6.39 6.39 - 6.42
Close: 6.59 - 6.64 6.64 - 6.68

Technical analysis

as of: 2022-05-13 4:36:04 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 8.35     One year: 9.46
Support: Support1: 5.61    Support2: 4.67
Resistance: Resistance1: 7.15    Resistance2: 8.1
Pivot: 7
Moving Average: MA(5): 6.61     MA(20): 7.18
MA(100): 7.44     MA(250): 7.75
MACD: MACD(12,26): -0.3     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 37.8     %D(3): 42
RSI: RSI(14): 41.1
52-week: High: 10.09  Low: 5.61
Average Vol(K): 3-Month: 92 (K)  10-Days: 59 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ACHV ] has closed above bottom band by 25.1%. Bollinger Bands are 14.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 14 May 2022
Achieve Life Sciences (NASDAQ:ACHV) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS - Defense World

Thu, 12 May 2022
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha

Thu, 12 May 2022
Achieve Life Sciences Tops Q1 EPS by 1c By -

Thu, 12 May 2022
MEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congress - Yahoo Finance

Wed, 11 May 2022
Notable earnings after Thursday's close - Seeking Alpha

Wed, 27 Apr 2022
ACHV stock gains on late-stage data for smoking cessation agent (NASDAQ:ACHV) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 9 (M)
Shares Float 8 (M)
% Held by Insiders 0.4 (%)
% Held by Institutions 29.8 (%)
Shares Short 312 (K)
Shares Short P.Month 339 (K)

Stock Financials

EPS -4.08
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.97
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -47.2
Return on Equity (ttm) -101.5
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -3.47
Qtrly Earnings Growth 0
Operating Cash Flow -29 (M)
Levered Free Cash Flow -17 (M)

Stock Valuations

PE Ratio -1.63
PEG Ratio -0.2
Price to Book value 2.23
Price to Sales 0
Price to Cash Flow -2.14

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2020-07-30
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.